{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-0", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 0, "text": "Meningococcal ACWY Vaccines (MenACWY): MedlinePlus Drug Information\nwebsite belongs to an official government organization in the United States.\n(\nLock\nmeans you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n→\n→\nMeningococcal ACWY Vaccines (MenACWY)\nMeningococcal ACWY Vaccines (MenACWY)\nWhat is meningococcal disease?\nWho should get meningococcal vaccine and when?\nTalk with your healthcare provider\nWhat are the risks from meningococcal vaccines?\nWhat if there is a severe reaction?\nThe National Vaccine Injury Compensation Program\nHow can I learn more?\nBrand names\nBrand names of combination products\nOther names\nWhat is meningococcal disease?\nMeningococcal ACWY vaccine can help protect against meningococcal disease caused by serogroups A, C, W, and Y. A different meningococcal vaccine is available that can help protect against serogroup B.\nMeningococcal disease can cause meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-1", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 1, "text": "ease can cause meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, loss of limbs, nervous system problems, or severe scars from skin grafts.\nMeningococcal disease is rare and has declined in the United States since the 1990s. However, it is a severe disease with a significant risk of death or lasting disabilities in people who get it.\nAnyone can get meningococcal disease but certain people are at increased risk, including:\nInfants younger than one year old\nAdolescents and young adults 16 through 23 years old\nPeople with certain medical conditions that affect the immune system\nMicrobiologists who routinely work with isolates of\nN."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-2", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 2, "text": "nger than one year old\nAdolescents and young adults 16 through 23 years old\nPeople with certain medical conditions that affect the immune system\nMicrobiologists who routinely work with isolates of\nN. meningitidis\n, the bacteria that cause meningococcal disease\nPeople at risk because of an outbreak in their community\nWho should get meningococcal vaccine and when?\nAdolescents need 2 doses of a meningococcal ACWY vaccine:\nFirst dose: 11 or 12 year of age\nSecond (booster) dose: 16 years of age\nIn addition to routine vaccination for adolescents, meningococcal ACWY vaccine is also recommended for certain groups of people:\nPeople at risk because of a serogroup A, C, W, or Y meningococcal disease outbreak\nPeople with HIV\nAnyone whose spleen is damaged or has been removed, including people with sickle cell disease\nAnyone with a rare immune system condition called \"persistent complement component deficiency\"\nAnyone taking a drug called a \"complement inhibitor,\" such as eculizumab (also called \"Soliris\"\n®\n) or ravulizumab (also called \"Ultomiris\"\n®\n)\nMicrobiologists who routinely work with isolates of\nN."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-3", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 3, "text": "Anyone taking a drug called a \"complement inhibitor,\" such as eculizumab (also called \"Soliris\"\n®\n) or ravulizumab (also called \"Ultomiris\"\n®\n)\nMicrobiologists who routinely work with isolates of\nN. meningitidis\nAnyone traveling to, or living in, a part of the world where meningococcal disease is common, such as parts of Africa\nCollege freshmen living in residence halls who have not been completely vaccinated with meningococcal ACWY vaccine\nU.S. military recruits\nTalk with your healthcare provider\nTell your vaccination provider if the person getting the vaccine:\nHas had an allergic reaction after a previous dose of meningococcal ACWY vaccine, or has any severe, life-threatening allergies\nIn some cases, your health care provider may decide to postpone meningococcal ACWY vaccination until a future visit.\nThere is limited information on the risks of this vaccine for pregnant or breastfeeding women, but no safety concerns have been identified. A pregnant or breastfeeding woman should be vaccinated if indicated.\nPeople with minor illnesses, such as a cold, may be vaccinated."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-4", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 4, "text": "breastfeeding women, but no safety concerns have been identified. A pregnant or breastfeeding woman should be vaccinated if indicated.\nPeople with minor illnesses, such as a cold, may be vaccinated. People who are moderately or severely ill should usually wait until they recover before getting meningococcal ACWY vaccine.\nYour health care provider can give you more information.\nWhat are the risks from meningococcal vaccines?\nRedness or soreness where the shot is given can happen after meningococcal ACWY vaccination\nA small percentage of people who receive meningococcal ACWY vaccine experience muscle pain, headache, or tiredness.\nPeople sometimes faint after medical procedures, including vaccination. Tell your provider if you feel dizzy or have vision changes or ringing in the ears.\nAs with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.\nWhat if there is a severe reaction?\nAn allergic reaction could occur after the vaccinated person leaves the clinic."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-5", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 5, "text": "ce of a vaccine causing a severe allergic reaction, other serious injury, or death.\nWhat if there is a severe reaction?\nAn allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.\nFor other signs that concern you, call your health care provider.\nAdverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself. Visit the VAERS website at\nhttps://www.vaers.hhs.gov\nor call\n1-800-822-7967\n.\nVAERS is only for reporting reactions, and VAERS does not give medical advice.\nThe National Vaccine Injury Compensation Program\nThe National Vaccine Injury Compensation Program (VICP) is a federal program that was created to compensate people who may have been injured by certain vaccines. Claims regarding alleged injury or death due to vaccination have a time limit for filing, which may be as short as two years."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020-6", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a607020.txt", "chunk_index": 6, "text": "eated to compensate people who may have been injured by certain vaccines. Claims regarding alleged injury or death due to vaccination have a time limit for filing, which may be as short as two years. Visit the VICP website at\nhttps://www.hrsa.gov/vaccinecompensation\nor call\n1-800-338-2382\nto learn about the program and about filing a claim.\nHow can I learn more?\nAsk your healthcare provider.\nCall your local or state health department.\nVisit the website of the Food and Drug Administration (FDA) for vaccine package inserts and additional information at\nhttps://www.fda.gov/vaccines-blood-biologics/vaccines\n.\nContact the Centers for Disease Control and Prevention (CDC): Call\n1-800-232-4636\n(\n1-800-CDC-INFO\n) or visit CDC's website at\nhttps://www.cdc.gov/vaccines\nBrand names\nMenactra\n®\nMenomune\n®\nMenveo\n®\nBrand names of combination products\nMenHibrix\n®\n(containing Haemophilus influenzae type b, Meningococcal Vaccine)\nOther names\nMenACWY\nLast Revised -\n03/15/2025"}
